Racial Disparities in Radiotherapy Regimens for Prostate and Breast Cancer
Black cancer patients are less likely than their White counterparts to receive shorter radiotherapy regimens, a study suggests.
Genitourinary Cancer
Serial SBRT Potentially Beneficial in Oligometastatic Prostate Cancer
Serial stereotactic body radiation therapy directed by PET using novel radiotracers may offer clinical benefits in patients with oligometastatic prostate cancer.
Enzalutamide, Abiraterone Compared for mCRPC With Comorbidities
Patients with comorbidities are not routinely included in clinical trials.
Cancer-Related Mortality Tied to Residential Segregation
Residential racial and economic segregation across US counties is associated with higher cancer mortality, a study suggests.
Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
A more than 2-fold increased risk of prostate cancer was seen for patients whose first melanoma diagnosis was 10 to 15 years before study recruitment.
Post-Cystectomy Long-Term Follow-Up Needed Even If No Sign of Bladder Cancer
Recurrence of bladder cancer after radical cystectomy can occur up to 4 years after surgery, a study suggests.
Medicine vs Food: The Patient Care Dilemma of Financial Toxicity
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
AEs Related to Antibody-Drug Conjugates Most Common in Breast Cancer
Researchers have characterized treatment-related adverse events associated with antibody-drug conjugates in clinical trials.
Metastasis-Directed Therapy Alone May Treat Solitary Prostate Cancer Recurrence
This is the first study to assess the role of metastasis-directed therapy in solitary metastatic oligorecurrent prostate cancer in the absence of systemic therapy.
18F-NaF PET-CT More Accurate Than 99mTc-MDP SPECT for Detecting Bone Metastasis
Results of a phase 3 trial suggest 18F-NaF PET-CT is more effective than 99mTc-MDP SPECT for detecting bone metastasis in patients with breast or prostate cancer.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...